McKesson’s Mike Cihlar outlines the ways that pharmacy’s strengths have shown throughout the pandemic and what it means for the future of the industry.
Micah Cost will join the Pharmacy Quality Alliance as CEO on Feb. 1, succeeding Laura Cranston, who has held the position since 2006 and announced her planned departure in June.
Amphastar's generic is a synthetic peptide product that the FDA has deemed to be bioequivalent and thus therapeutically equivalent to Eli Lilly’s Glucagon Emergency Kit for Low Blood Sugar.